Combined Chemoradiotherapy Regimens of Paclitaxel and Carboplatin for Locally Advanced Non–Small-Cell Lung Cancer: A Randomized Phase II Locally Advanced Multi-Modality Protocol von BELANI, Chandra P, CHOY, Hak, BONOMI, Phil, SCOTT, Charles, TRAVIS, Patrick, HALUSCHAK, John, CURRAN, Walter J

Volltext

Expanding Access to Lung Cancer Clinical Trials by Reducing the Use of Restrictive Exclusion Criteria: Perspectives of a Multistakeholder Working Group von Forde, Patrick M., Bonomi, Phil, Shaw, Alice, Blumenthal, Gideon M., Ferris, Andrea, Patel, Chirag, Melemed, Allen, Basu Roy, Upal, Ramamoorthy, Anuradha, Liu, Qi, Burns, Timothy, Gainor, Justin F., Lovly, Christine, Piotrowska, Zofia, Lehman, Jonathan, Selig, Wendy

Volltext

Reducing Uninformative IND Safety Reports: A List of Serious Adverse Events anticipated to Occur in Patients with Lung Cancer von Bonomi, Phil, Stuccio, Nina, Delgra, C. J., Chuk, Meredith K., Spira, Alexander, Deitz, Anne C., Blumenthal, Gideon M., Ferris, Andrea, Gong, Yutao, He, Jinghua, Basu Roy, Upal, Selig, Wendy

Volltext

Comparison of several model-based methods for analysing incomplete quality of life data in cancer clinical trials von Fairclough, Diane L., Peterson, Harriet F., Cella, David, Bonomi, Phil

Volltext

O-263 Randomized 3-arm phase II study of paclitaxel (T), carboplatin (C), and thoracic radiation (TRT) for patients with stage III non-small cell lung cancer (NSCLC). Report of loc... von Bonomi, Phil, Curran, Walter, Choy, Hak, Scott, Charles, Travis, Patrick, Haluschak, John J., Belani, Chandra P.

Volltext